These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 21745)
1. Selective tumor DNA synthesis inhibition: in vivo prodrug activation by an exogenous enzyme. Tschiersch B; Schwabe K; Sydow G; Graffi A Cancer Treat Rep; 1977 Nov; 61(8):1489-93. PubMed ID: 21745 [TBL] [Abstract][Full Text] [Related]
2. [Selective variations in toxicity of new transport forms of carcinostatics produced by exogenous enzymes. 2. Beta-peltatin A-alpha-L-arabinofuranoside and alpha-L-arabinofuranosidase]. Tschiersch B; Schwabe K; Sydow G; Graffi A Pharmazie; 1978 Jun; 33(6):358-61. PubMed ID: 28536 [No Abstract] [Full Text] [Related]
3. Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes. Graffi A; Arnold W; Sydow G; Schwabe K; Arndt D; Pehl E Neoplasma; 1978; 25(4):377-84. PubMed ID: 29245 [TBL] [Abstract][Full Text] [Related]
4. [Distribution studies of alpha-L-arabinofuranosidase already unstable at pH 7.0 (37 degrees C) in tumor-bearing mice in connection with its possible use to enhance the selectivity of the chemotherapy of malignant tumors]. Butschak G; Schulze B; Küster A; Niederhausen T; Niemeyer U; Graffi A Arch Geschwulstforsch; 1990; 60(3):193-200. PubMed ID: 2369282 [TBL] [Abstract][Full Text] [Related]
5. [Selective toxicity of new carcinostatic transport forms produced by exogenous enzymes. 1. 6-mercaptopurine-S-beta-D-xyloparanoside and beta-xylopyranosidase]. Tschiersch B; Schwabe K; Graffi A Pharmazie; 1977; 32(8-9):465-7. PubMed ID: 22874 [No Abstract] [Full Text] [Related]
6. [Pharmacokinetic studies of the activity of a pH-labile alpha-L-arabinofuranosidase following i.v. injection into tumor-bearing mice]. Butschak G; Schulze B; Küster A; Niederhausen T; Niemeyer U; Graffi A Arch Geschwulstforsch; 1989; 59(5):325-31. PubMed ID: 2589931 [TBL] [Abstract][Full Text] [Related]
7. [Experiments on the modification of the distribution of the activity of various alpha-L-arabinofuranosidases following i.v. application in tumor-bearing mice]. Butschak G; Schulze B; Küster A; Niederhausen T; Niemeryer U; Graffi A Arch Geschwulstforsch; 1989; 59(6):407-13. PubMed ID: 2596956 [TBL] [Abstract][Full Text] [Related]
8. DNA repair in normal and preneoplastic mammary tissues. Bodell WJ; Banerjee MR Cancer Res; 1978 Mar; 38(3):736-40. PubMed ID: 626977 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors. Branunschweiger PG; Schiffer LM Cancer Treat Rep; 1978 May; 62(5):727-36. PubMed ID: 657158 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacocinetic behaviour of alpha-L-arabinofuranosidase in therapeutical application to toxify transport forms of cancerostatic substances (author's transl)]. Butschak G; Sydow G; Graffi A; Pehl E; Sydow H Arch Geschwulstforsch; 1976; 46(5):365-75. PubMed ID: 1021009 [TBL] [Abstract][Full Text] [Related]
11. [Histo- and cytochemical demonstration of exogenous alpha-L-arabinofuranosidase in tumor and tissues in mice (author's transl)]. Fey F; Arndt D; Ziebarth C Acta Histochem; 1980; 67(1):17-21. PubMed ID: 6778057 [TBL] [Abstract][Full Text] [Related]
12. Protective, tumor-selective dual pathway activation of 5-fluoro-2'-deoxycytidine provided by tetrahydrouridine in mice bearing mammary adenocarcinoma-755. Boothman DA; Briggle TV; Greer S Cancer Res; 1987 May; 47(9):2344-53. PubMed ID: 2436761 [TBL] [Abstract][Full Text] [Related]
13. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Jähde E; Glüsenkamp KH; Klünder I; Hülser DF; Tietze LF; Rajewsky MF Cancer Res; 1989 Jun; 49(11):2965-72. PubMed ID: 2720657 [TBL] [Abstract][Full Text] [Related]
14. In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors. Braunschweiger PG; Poulakos L; Schiffer LM Cancer Res; 1976 May; 36(5):1748-53. PubMed ID: 1268832 [TBL] [Abstract][Full Text] [Related]
15. [Effects of 4-(4"-(2",2",6",6"-tetramethyl-1"-pipe-ridinyloxy) amino)-4'-demethylepipodophyllotoxin on nucleic acids, proteins, and DNA strand of L7712 cells in vitro]. He XQ; Zhang PY; Tian X; Li JX Zhongguo Yao Li Xue Bao; 1992 May; 13(3):276-9. PubMed ID: 1442115 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro. Yalowich JC; Goldman ID Cancer Res; 1984 Mar; 44(3):984-9. PubMed ID: 6692420 [TBL] [Abstract][Full Text] [Related]
17. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors. Braunschweiger PG; Schiffer LM Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093 [TBL] [Abstract][Full Text] [Related]
18. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies. Mekras JA; Boothman DA; Perez LM; Greer S Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164 [TBL] [Abstract][Full Text] [Related]
19. Actions of exogenous histones and other proteins on [3H]-thymidine incorporation into DNA of Novikoff hepatoma cells. Barra R; Beres B; Koch MR; Lea MA Cytobios; 1976; 17(66):123-36. PubMed ID: 198183 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA synthesis by retinyl acetate during chemically induced mammary carcinogenesis. Mehta RG; Moon RC Cancer Res; 1980 Apr; 40(4):1109-11. PubMed ID: 6766804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]